Acta Med. 2007, 50: 29-33
https://doi.org/10.14712/18059694.2017.56
Essential PTX3 Biology (not only) for Cardiologists and Cardiac Surgeons
References
1. Nat Immunol 2004; 5:678–84.
< AL, Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. https://doi.org/10.1038/ni1082>
2. J Exp Med 2004; 199:1121–31.
< T, Rifkin I, Bonegio R, Hugel B, Freyssinet J-M, Sato K, et al. Impaired clearance of apoptotic cells promotes synergy between atherosclerosis and autoimmune disease. https://doi.org/10.1084/jem.20031557>
<PubMed>
3. J Leukocyte Biol 2006; 80:87–95.
< P, Dumitriu IE, Peri G, Russo V, Mantovani A, Manfredi AA, Rovere- Querini P. The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. https://doi.org/10.1189/jlb.0805445>
4. Blood 2006; 107:151–8.
< P, Propato A, Dumitriu IE, Rovere-Querini P, Russo V, Fontana R, et al. The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells and edits the cross-presentation of self, viral and tumor antigens. https://doi.org/10.1182/blood-2005-03-1112>
5. Immunol Today 1994; 15: 74–80.
< H, Gauldie J. The acute phase response. https://doi.org/10.1016/0167-5699(94)90137-6>
6. J Exp Med 2002; 196:1099–104.
< GT, Behrens GMN, Smith CM, Miller JFAP, Jones C, Lejon K, et al. The CD8alpha (+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. https://doi.org/10.1084/jem.20020861>
<PubMed>
7. J Biol Chem 1997; 272:32817–23.
< B, Vouret-Craviari V, Bastone A, De Gioia L, Matteucci C, Peri G, et al. Multimer formation and ligand recognition by the long pentraxin PTX3-similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. https://doi.org/10.1074/jbc.272.52.32817>
8. Bozza S, Bistoni F, Gaziano R, Pitzurra L, Zelante T, Bonifazi P, et al. Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood First Edition Paper.
<https://doi.org/10.1182/blood-2006-03-009266>
9. J Biol Chem 1992; 267:22190–7.
F, d’Aniello EM, Golay J, Peri G, Bottazzi B, Bairoch A, et al. Interleukin- 1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component.
10. J Exp Med 2002; 196: 947–55.
< GM, Kurts C, Miller JFAP, Bouillet P, Strasser A, Brooks AG, Carbone FR, Heath WR. Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. https://doi.org/10.1084/jem.20020827>
<PubMed>
11. J Leukocyte Biol 2004; 75:649–56.
< SN, Nomizo R, Cisalpino PS, Teixeira MM, Brown GD, Mantovani A, et al. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages. https://doi.org/10.1189/jlb.0803371>
12. J Leukocyte Biol 2006; 79:797–802.
< A, Michela M, Bottazzi B, Peri G, Valentino S, Polentarutti N, Garlanda C, Mantovani A. Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-γ. https://doi.org/10.1189/jlb.0905493>
13. J Clin Invest 1998; 101:890–8.
< VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. https://doi.org/10.1172/JCI1112>
<PubMed>
14. Arthritis Rheum 2001; 44:2841–50.
< F, Peri G, Doni A, Dell’Antonio G, Dal Cin E, Bozzolo E, et al. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation. https://doi.org/10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6>
15. J Immunol 2002; 168:5589–95.
< TA, Herndon J, Elzey B, Griffith TS, Schoenberger S, Green DR. Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and crosspriming of CD8(+) T cells produce active immune unresponsiveness. https://doi.org/10.4049/jimmunol.168.11.5589>
16. Nature 2002; 420:182–6.
< C, Hirsch E, Bozza S, Salustri M, De Acetis R, Nota A, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. https://doi.org/10.1038/nature01195>
17. J Exp Med 2000; 192:1353–64.
< D, Kim SJ, Brot N, Elkon KB. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response: implications for systemic autoimmunity. https://doi.org/10.1084/jem.192.9.1353>
<PubMed>
18. Immunol Rev 2004; 199:9–26.
< WR, Belz GT, Behrens GMN, Smith CM, Forehan SP, Parish IA, et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. https://doi.org/10.1111/j.0105-2896.2004.00142.x>
19. Blood 1996; 87:1862–72.
M, Vidal Alles V, Castellano M, Picardi G, De Gioia L, Bottazzi B, et al. Cloning of mouse PTX3, a new member of the pentraxin gene family expressed at extrahepatic sites.
20. Immunity 2005; 22:551–60.
< P, Bottazzi B, Sironi M, Doni A, Rusnati M, Presta M, et al. Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. https://doi.org/10.1016/j.immuni.2005.03.008>
21. Nat Immunol 2000; 1:502–9.
< P, Renno T, Goetsch L, Miconnet I, Aubry JP, Delneste Y, et al. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. https://doi.org/10.1038/82751>
22. AIDS 2002; 16:F9–F18.
< M, Brockmeyer N, Knabbe C, Rose-John S. Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi’s sarcoma cells. https://doi.org/10.1097/00002030-200205240-00001>
23. Atherosclerosis 2004; 175:221–8.
< M, Peri G, Knabbe C, Eckstein HH, Schmid FX, Schmitz G, Mantovani A. Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. https://doi.org/10.1016/j.atherosclerosis.2004.03.020>
24. Circulation 2004; 110:2349–54.
< R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, et al., on behalf of the Lipid Assessment Trial Italian Network (LATIN) Investigators. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. https://doi.org/10.1161/01.CIR.0000145167.30987.2E>
25. J Immunol 1993; 150:1804–12.
GW, Lee TH, Vilček J. TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentraxin family of acute phase proteins.
26. Eur J Haematol 2000; 64:132–4.
< L, Pilastro MR, Vicari L, Di Marco R, Malaguarnera M, Messina A. PTX3 gene expression in Castleman’s disease. https://doi.org/10.1034/j.1600-0609.2000.9l071.x>
27. Immunol. Rev 2003; 196:125–46.
< AE, Thomson AW. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. https://doi.org/10.1046/j.1600-065X.2003.00079.x>
28. Arterioscler Thromb Vasc Biol 2002; 22:782–7.
< E, Di Santo A, Bastone A, Peri G, Mantovani A, de Gaetano G, et al. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation. https://doi.org/10.1161/01.ATV.0000012282.39306.64>
29. Eur J Immunol 2003; 33:465–73.
< AJ, Bottazzi B, Mantovani A, Salvatori G, Kishore U, Schwaeble WJ, et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. https://doi.org/10.1002/immu.200310022>
30. Trends Immunol 2003; 24:148–54.
< AJ, Daha MR, van Kooten C, Roos A. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. https://doi.org/10.1016/S1471-4906(03)00030-9>
31. Circulation 2000; 102:636–41.
< G, Introna M, Corradi D, Iacuitti G, Signorini S, Avanzini F, et al. PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. https://doi.org/10.1161/01.CIR.102.6.636>
32. J Immunol 2002; 169: 6733–42.
< MC, Sigal LJ. Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. https://doi.org/10.4049/jimmunol.169.12.6733>
33. Immunol Rev 2005; 207:166–83.
< KL, Shen L. Cross-presentation: underlying mechanisms and role in immune surveillance. https://doi.org/10.1111/j.0105-2896.2005.00301.x>
34. Arterioscler Thromb Vasc Biol 2002; 22:e10–e14.
< MS, Zimmer S, Bottazzi B, Garlanda C, Mantovani A, Hansson GK. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. https://doi.org/10.1161/01.ATV.0000015595.95497.2F>
35. Blood 2000; 96:4300–6.
P, Peri G, Fazzini F, Bottazzi B, Doni A, Bondanza A, et al. The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells.
36. Apoptosis 2003; 8:469–79.
< P, Dumitriu IE. Corpse disposal after apoptosis. https://doi.org/10.1023/A:1025538324077>
37. Infect Immun 1997; 65: 1345–50.
V, Matteucci C, Peri G, Poli G, Introna M, Mantovani A. Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan.
38. Cytokine Growth Factor Rev 2004; 15:129–46.
< H-G, Vilček J. Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. https://doi.org/10.1016/j.cytogfr.2004.01.005>